Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer

• 收藏
• 分享

专利权人:

Genentech, Inc.;Board of Regents, The University of Texas System; Inc.;Genentech

发明人:

Merchant, Mark,Sampath, Deepak,Konopleva, Marina Yurievna,Han, Lina

申请号：

AU2016349279

公开号：

AU2016349279A1

申请日:

2016.11.03

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention is directed to a combination therapy involving a selective Bcl-2 inhibitor and a MEK inhibitor for the treatment of a patient in need of such a therapy. The patient in need of the combination therapy is suffering from cancer, such as acute myeloid leukemia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/